IONS vs LII · rev $514.0M vs P/E 27, rev $1.20B
Ionis Pharmaceuticals Inc (IONS) versus Lennox International Inc (LII) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Lennox International Inc (LII) is a building products & equipment company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported LII revenue for 2025-12-31 was $1.20B. Net income was $142.5M. Revenue was down 77.6% from 2024-12-31 to 2025-12-31. LII currently screens at market cap $21.44B and trailing P/E 26.9.
IONS currently screens at market cap $12.28B. LII currently screens at market cap $21.44B and trailing P/E 26.9.
Not investment advice. Open the IONS and LII stock pages for the full models.
Not investment advice.